Cargando…

Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)

Detalles Bibliográficos
Autores principales: Viúdez, Antonio, Carvalho, Filipe L.F., Maleki, Zahra, Zahurak, Marianna, Laheru, Daniel, Stark, Alejandro, Azad, Nilofer S., Wolfgang, Christopher L., Baylin, Stephen, Herman, James G., De Jesus-Acosta, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392354/
https://www.ncbi.nlm.nih.gov/pubmed/28407701
http://dx.doi.org/10.18632/oncotarget.16155
_version_ 1783229435038662656
author Viúdez, Antonio
Carvalho, Filipe L.F.
Maleki, Zahra
Zahurak, Marianna
Laheru, Daniel
Stark, Alejandro
Azad, Nilofer S.
Wolfgang, Christopher L.
Baylin, Stephen
Herman, James G.
De Jesus-Acosta, Ana
author_facet Viúdez, Antonio
Carvalho, Filipe L.F.
Maleki, Zahra
Zahurak, Marianna
Laheru, Daniel
Stark, Alejandro
Azad, Nilofer S.
Wolfgang, Christopher L.
Baylin, Stephen
Herman, James G.
De Jesus-Acosta, Ana
author_sort Viúdez, Antonio
collection PubMed
description
format Online
Article
Text
id pubmed-5392354
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53923542017-04-21 Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET) Viúdez, Antonio Carvalho, Filipe L.F. Maleki, Zahra Zahurak, Marianna Laheru, Daniel Stark, Alejandro Azad, Nilofer S. Wolfgang, Christopher L. Baylin, Stephen Herman, James G. De Jesus-Acosta, Ana Oncotarget Correction Impact Journals LLC 2017-03-13 /pmc/articles/PMC5392354/ /pubmed/28407701 http://dx.doi.org/10.18632/oncotarget.16155 Text en Copyright: © 2017 Viúdez et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Viúdez, Antonio
Carvalho, Filipe L.F.
Maleki, Zahra
Zahurak, Marianna
Laheru, Daniel
Stark, Alejandro
Azad, Nilofer S.
Wolfgang, Christopher L.
Baylin, Stephen
Herman, James G.
De Jesus-Acosta, Ana
Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)
title Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)
title_full Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)
title_fullStr Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)
title_full_unstemmed Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)
title_short Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)
title_sort correction: a new immunohistochemistry prognostic score (ips) for recurrence and survival in resected pancreatic neuroendocrine tumors (pannet)
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392354/
https://www.ncbi.nlm.nih.gov/pubmed/28407701
http://dx.doi.org/10.18632/oncotarget.16155
work_keys_str_mv AT viudezantonio correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet
AT carvalhofilipelf correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet
AT malekizahra correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet
AT zahurakmarianna correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet
AT laherudaniel correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet
AT starkalejandro correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet
AT azadnilofers correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet
AT wolfgangchristopherl correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet
AT baylinstephen correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet
AT hermanjamesg correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet
AT dejesusacostaana correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet